Corrigendum to “SiRNA-based delivery nanoplatform attenuates the CRC progression via HIF1α-AS2” [Nano Today 47 (2022) 101667]Qingtao Meng, Rui Chen, Hongbao Yang et al.|Nano Today|2024Cited by 0